Cargando…

LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway

BACKGROUND: Brain metastasis (BM) is associated with poor prognosis, recurrence, and death in patients with non-small cell lung cancer (NSCLC). Lysophosphatidylcholine acyltransferase 1 (LPCAT1) has been reported to be involved in the progression, metastasis and recurrence of malignancies. However,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Chunhua, Dong, Xiaomin, Lu, Hui, Tong, Fan, Chen, Lingjuan, Zhang, Ruiguang, Dong, Jihua, Hu, Yu, Wu, Gang, Dong, Xiaorong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385475/ https://www.ncbi.nlm.nih.gov/pubmed/30791942 http://dx.doi.org/10.1186/s13046-019-1092-4

Ejemplares similares

LPCAT1 promotes gefitinib resistance via upregulation of the EGFR/PI3K/AKT signaling pathway in lung adenocarcinoma
por: Ding, Jianghua, et al.
Publicado: (2022)

MicroRNA-330-3p promotes brain metastasis and epithelial-mesenchymal transition via GRIA3 in non-small cell lung cancer
por: Wei, Chunhua, et al.
Publicado: (2019)

Comprehensive Analysis of LPCATs Highlights the Prognostic and Immunological Values of LPCAT1/4 in Hepatocellular Carcinoma
por: Lin, Tong, et al.
Publicado: (2021)

T Cell-Mediated Tumor Killing-Related Classification of the Immune Microenvironment and Prognosis Prediction of Lung Adenocarcinoma
por: Ding, Peng, et al.
Publicado: (2022)

The Research Progress of PD-1/PD-L1 Inhibitors Enhancing Radiotherapy Efficacy
por: Wen, Lu, et al.
Publicado: (2021)

Prognostic implications of immunohistochemistry markers for EGFR-TKI therapy in Chinese patients with advanced lung adenocarcinoma harboring EGFR mutations
por: Zhang, Ruiguang, et al.
Publicado: (2016)

β-Trcp and CK1δ-mediated degradation of LZTS2 activates PI3K/AKT signaling to drive tumorigenesis and metastasis in hepatocellular carcinoma
por: Lu, Yanwei, et al.
Publicado: (2021)

LPCAT1 overexpression promotes the progression of hepatocellular carcinoma
por: He, Rong-Quan, et al.
Publicado: (2021)

Lpcat3 deficiency promotes palmitic acid-induced 3T3-L1 mature adipocyte inflammation through enhanced ROS generation: Lpcat3 deficiency promotes adipocyte inflammation
por: Hu, Jiachun, et al.
Publicado: (2022)

Ferroptosis-related genes LPCAT3 and PGD are potential diagnostic biomarkers for osteoarthritis
por: Wang, Lufei, et al.
Publicado: (2023)

SKA3 promotes lung adenocarcinoma metastasis through the EGFR–PI3K–Akt axis
por: Hu, Dan-dan, et al.
Publicado: (2020)

LPCAT2 controls chemoresistance in colorectal cancer
por: Cotte, Alexia Karen, et al.
Publicado: (2018)

ZNF692 promotes colon adenocarcinoma cell growth and metastasis by activating the PI3K/AKT pathway
por: Xing, Yanwei, et al.
Publicado: (2019)

Ovarian metastasis from non-small cell lung cancer with ALK and EGFR mutations: A report of two cases
por: Mushi, Rosemary T., et al.
Publicado: (2016)

Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancer
por: Lebok, Patrick, et al.
Publicado: (2019)

Overexpression of LPCAT1 enhances endometrial cancer stemness and metastasis by changing lipid components and activating TGF-β/Smad2/3 signaling pathway: Tumor-promoting effect of LPCAT1 in endometrial cancer
por: Zhao, Tianyi, et al.
Publicado: (2022)

Up-regulation of the PI3K/AKT and RHO/RAC/PAK signalling pathways in CHK1 inhibitor resistant Eµ-Myc lymphoma cells
por: Hunter, Jill E., et al.
Publicado: (2022)

Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway
por: Liang, Jinghui, et al.
Publicado: (2020)

Curcumol Inhibits Lung Adenocarcinoma Growth and Metastasis via Inactivation of PI3K/AKT and Wnt/β-Catenin Pathway
por: Li, Sheng, et al.
Publicado: (2021)

Tetraspanin 1 promotes epithelial-to-mesenchymal transition and metastasis of cholangiocarcinoma via PI3K/AKT signaling
por: Wang, Yan, et al.
Publicado: (2018)

ROBO4 deletion ameliorates PAF-mediated skin inflammation via regulating the mRNA translation efficiency of LPCAT1/LPCAT2 and the expression of PAF receptor
por: Xiao, Xiaoqiang, et al.
Publicado: (2020)

Pan-cancer analysis identifies LPCATs family as a prognostic biomarker and validation of LPCAT4/WNT/β-catenin/c-JUN/ACSL3 in hepatocellular carcinoma
por: Lu, Yaoyong, et al.
Publicado: (2023)

lncRNA UCA1 Promotes Gefitinib Resistance as a ceRNA to Target FOSL2 by Sponging miR-143 in Non-small Cell Lung Cancer
por: Chen, Xiliu, et al.
Publicado: (2019)

Shikonin exerts antitumor activity in Burkitt’s lymphoma by inhibiting C-MYC and PI3K/AKT/mTOR pathway and acts synergistically with doxorubicin
por: Ni, Fan, et al.
Publicado: (2018)

LPCAT1 controls phosphate homeostasis in a zinc-dependent manner
por: Kisko, Mushtak, et al.
Publicado: (2018)

LPCAT1 reprogramming cholesterol metabolism promotes the progression of esophageal squamous cell carcinoma
por: Tao, Mingyue, et al.
Publicado: (2021)

ZCCHC12 promotes the progression of osteosarcoma via PI3K/AKT pathway
por: Cui, Yong, et al.
Publicado: (2022)

Downregulation of BRD4 inhibits gallbladder cancer proliferation and metastasis and induces apoptosis via PI3K/AKT pathway
por: Hao, Jiaqi, et al.
Publicado: (2017)

PI3K/AKT/mTOR-Targeted Therapy for Breast Cancer
por: Zhu, Kunrui, et al.
Publicado: (2022)

Sensing and Integration of Erk and PI3K Signals by Myc
por: Lee, Tae, et al.
Publicado: (2008)

Integrated circulating tumor DNA and T cell repertoire predict radiotherapeutic response and outcome in non‐small cell lung cancer patients with brain metastasis
por: Peng, Ling, et al.
Publicado: (2023)

Epithelial V‐like antigen 1 promotes hepatocellular carcinoma growth and metastasis via the ERBB‐PI3K‐AKT pathway
por: Ni, QianZhi, et al.
Publicado: (2020)

Tumor-associated macrophages affect the biological behavior of lung adenocarcinoma A549 cells through the PI3K/AKT signaling pathway
por: Yuan, Shiyang, et al.
Publicado: (2019)

SIRT3 inhibits prostate cancer by destabilizing oncoprotein c-MYC through regulation of the PI3K/Akt pathway
por: Quan, Yizhou, et al.
Publicado: (2015)

Combinatorial inhibition of BTK, PI3K-AKT and BRD4-MYC as a strategy for treatment of mantle cell lymphoma
por: Vann, Kendra R., et al.
Publicado: (2022)

NVS-ZP7-4 inhibits hepatocellular carcinoma tumorigenesis and promotes apoptosis via PI3K/AKT signaling
por: Tong, Qing, et al.
Publicado: (2023)

Association of HOTAIR expression with PI3K/Akt pathway activation in adenocarcinoma of esophagogastric junction
por: Hui, Zhang, et al.
Publicado: (2016)

Agmatinase promotes the lung adenocarcinoma tumorigenesis by activating the NO-MAPKs-PI3K/Akt pathway
por: Zhu, Hui-er, et al.
Publicado: (2019)

Phosphatidylcholine formation by LPCAT1 is regulated by Ca(2+) and the redox status of the cell
por: Soupene, Eric, et al.
Publicado: (2012)

LPCAT1 functions as a novel prognostic molecular marker in hepatocellular carcinoma
por: Zhang, Hongbin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7juunvte4f1hpvfct33069jh7o